12-05-2022, 08:24 AM
Quote:Conflict of interest leads member of special committee investigating Stanford president to step aside
...
Felix Baker, the only trustee who was appointed to the committee with a bioscience background, will no longer be a member of the committee. This comes after The Daily discovered that Baker’s investment firm, co-founded by him and his brother, maintains an $18 million stake in Denali Therapeutics, a biotechnology company co-founded by Tessier-Lavigne. Now serving on its board of directors and as a scientific advisor, Tessier-Lavigne maintains more than $50 million of stock in Denali.
The Daily contacted Baker on Saturday via email requesting comment on the conflict of interest that could be posed by his stake in Tessier-Lavigne’s company. The Daily also sought comment from the University, which did not respond.
Aidan Ryan, who works at the world’s largest public relations firm Edelman, responded on behalf of the board Sunday afternoon, stating Baker removed himself from the committee “to avoid any questions of potential conflicts.”
https://stanforddaily.com/2022/12/05/con...tep-aside/
Eric
"the older we get the better we were"
